CSL Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CSL Limited with three other
pharmaceutical manufacturers in Australasia:
AFT Pharmaceuticals Ltd
of NEW ZEALAND
sales of 113.11 million New Zealand Dollars [US$79.76 million]
of which 60%
(120.51 million Australian Dollars [US$87.83 million]
Mayne Pharma Group Limited
(401.47 million Australian Dollars [US$292.61 million]
of which 51%
was Generic Products).
CSL Limited reported sales of A$13.80 billion (US$10.06 billion)
June of 2021.
a very small
increase of 1.1%
versus 2020, when the company's sales were A$13.65 billion.
Sales at CSL Limited have increased during each of the previous five years
(and since 2016, sales have increased a total of 64%).
Sales of Seqirus saw an increase
that was more than double the company's growth rate: sales were up
37.2% in 2021, from
A$1.69 billion to A$2.32 billion.